Table 1.
Main baseline clinical and demographic characteristics of the study sample.
| Variable | Overall (n = 23) | XEN 63 (n = 20) | Phaco + XEN63 (n = 3) |
|---|---|---|---|
| Age, years | |||
| Mean ± SD | 67.8 ± 15.3 | 67.3 ± 15.9 | 71.3 ± 12.4 |
| Sex, n (%) | |||
| Women Men |
15 (65.2) 8 (34.8) |
14 (70.0) 6 (30.0) |
1 (33.3) 2 (66.7) |
| Type of glaucoma | |||
| POAG Uveitic PXG PACG Traumatic Missing information |
14 (60.9) 4 (17.4) 1 (4.3) 1 (4.3) 1 (4.3) 2 (8.7) |
12 (60.0) 3 (15.0) 1 (5.0) 1 (5.0) 1 (5.0) 2 (10.0) |
2 (66.7) 1 (33.3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) |
| Previous laser, n (%) | |||
| No SLT Nd:YAG Iridotomy |
21 (91.3) 1 (4.3) 1 (4.3) |
18 (90.0) 1 (5.0) 1 (5.0) |
3 (100.0) 0 (0.0) 0 (0.0) |
| Previous surgery *, n (%) | |||
| None Cataract Refractive (laser) Trabecular MIG Subconjunctival MIG |
2 (8.7) 14 (60.9) 3 (13.0) 2 (8.7) 2 (8.7) |
0 (0.0) 14 (70.0) 3 (15.0) 2 (10.0) 2 (10.0) |
3 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) |
| BCVA, ETDRS | |||
| Mean ± SD | 0.49 ± 0.26 | 0.54 ± 0.24 | 0.23 ± 0.15 |
| ECC | |||
| Mean ± SD | 2217.9 ± 343.1 | 2223.4 ± 297.0 | 2161.0 ± 563.8 |
| MD, dB | |||
| Mean ± SD | −17.03 ± 9.96 | −16.71 ± 10.51 | −18.23 ± 9.44 |
| PSD, dB | |||
| Mean ± SD | 7.00 ± 2.28 | 7.10 ± 3.08 | 6.66 ± 3.2 |
| NTOHM | |||
| Mean ± SD | 2.27 ± 0.94 | 2.26 ± 0.99 | 2.33 ± 0.58 |
| IOP, mm Hg | |||
| Mean ± SD | 27.0 ± 7.8 | 26.5 ± 8.2 | 30.3 ± 3.2 |
* Patients may have undergone more than one procedure. Abbreviations: Phaco: Phacoemulsification; SD: Standard deviation; POAG: Primary open-angle glaucoma; PXG: Pseudoexfolitive glaucoma; PACG: Primary angle-closure glaucoma; SLT: Selective laser trabeculoplasty; YAG: Neodymium-doped Yttrium Aluminium Garnet; MIG: Minimally invasive glaucoma device; BCVA: Best corrected visual acuity; ETDRS: Early treatment diabetic retinopathy study; ECC: Endothelial cell count; MD: Mean defect; PSD: Pattern standard deviation; NTOHM: Number of topical ocular hypotensive medications; IOP: Intraocular pressure.